HRGN's Forward Dividend Yield % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 3.12 * Ranked among companies with meaningful Forward Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Harvard Apparatus Regenerative Technology Forward Dividend Yield % Related Terms
HRGN vs DTEAF, STCB, JVA: Forward Dividend Yield % Comparison
For the Packaged Foods subindustry, Harvard Apparatus Regenerative Technology's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Harvard Apparatus Regenerative Technology Forward Dividend Yield % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Harvard Apparatus Regenerative Technology's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Harvard Apparatus Regenerative Technology's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Harvard Apparatus Regenerative Technology (HRGN) has a Forward Dividend Yield % of 0.00% as of Jun. 30, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Harvard Apparatus Regenerative Technology and its competitors. According to the industry distribution chart, Harvard Apparatus Regenerative Technology ranks #999999 out of 1159 companies in the Consumer Packaged Goods industry.
Is Harvard Apparatus Regenerative Technology's Forward Dividend Yield % too high?
Harvard Apparatus Regenerative Technology's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Harvard Apparatus Regenerative Technology ranks #999999 out of 1159 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Harvard Apparatus Regenerative Technology has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Harvard Apparatus Regenerative Technology's Forward Dividend Yield % compare to DTEAF and STCB?
According to the Consumer Packaged Goods industry distribution chart, Harvard Apparatus Regenerative Technology ranks #999999 out of 1159 companies for Forward Dividend Yield %. This places Harvard Apparatus Regenerative Technology in the lower half of its industry. The industry median Forward Dividend Yield % is 3.12. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Consumer Packaged Goods company?
The median Forward Dividend Yield % among Consumer Packaged Goods companies is 3.12, based on 1,159 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Harvard Apparatus Regenerative Technology and its competitors. For the Consumer Packaged Goods industry, the median Forward Dividend Yield % is 3.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Harvard Apparatus Regenerative Technology's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harvard Apparatus Regenerative Technology stock overvalued right now?
Based on GuruFocus' analysis, Harvard Apparatus Regenerative Technology (HRGN) is currently considered Possible Value Trap. The stock's GF Value™ is $5.34, compared to a current price of $1.28 — trading 76% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Harvard Apparatus Regenerative Technology's overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Harvard Apparatus Regenerative Technology (HRGN), the current Forward Dividend Yield % is 0.00% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Harvard Apparatus Regenerative Technology (HRGN) Overvalued in 2026?
Based on GuruFocus' analysis, Harvard Apparatus Regenerative Technology stock appears to be undervalued.
The current stock price of $1.28 is trading 76% below its estimated GF Value™ of $5.34.
GuruFocus considers Harvard Apparatus Regenerative Technology to be Possible Value Trap.
Key valuation signals for HRGN:
Forward Dividend Yield %: 0.00%
GF Value™: $5.34 vs. price of $1.28 (76% below fair value)
No single metric tells the full story. See the HRGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Harvard Apparatus Regenerative Technology Business Description
Harvard Apparatus Regenerative Technology is a clinical-stage biotechnology company focused on the development of regenerative medicine treatments for disorders of the gastrointestinal system and other organs that result from cancer, trauma, or birth defects. Its technology is based on a proprietary cell-therapy platform that uses a patient's own stem cells to regenerate and restore function to damaged organs. The Company has two operating and reportable segments: Regenerative Biotech, focused on the development of regenerative medicine treatments with operations currently in the United States, and Consumer Health Products relating to consumer health products with operations currently in Asia.
33GF Score
Get the complete analysis for HRGN
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HRGN has been successfully added to your 